MarketCap
Facebook
X
Telegram
Cigna Corporation Interest Expense | CI
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Cigna Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.41 B | -1.44 B | -1.45 B | -1.23 B | -1.21 B | -1.44 B | -1.68 B | -498 M | -252 M | -278 M | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -252 M | -1.68 B | -1.09 B |
Quarterly Interest Expense Cigna Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -333 M | -356 M | -357 M | -362 M | -347 M | -337 M | -362 M | -362 M | -376 M | -375 M | -322 M | -360 M | -365 M | -363 M | -358 M | -324 M | -304 M | -301 M | -299 M | -293 M | -303 M | -298 M | -314 M | -337 M | -336 M | -374 M | -391 M | -391 M | -411 M | -428 M | -452 M | - | -99 M | -56 M | -57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -56 M | -452 M | -327 M |
Interest Expense of other stocks in the Health care industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Humana
HUM
|
-451 M | $ 433.05 | 5.23 % | $ 52.2 B |  USA |
 |
NovoCure Limited
NVCR
|
22.2 M | $ 13.22 | -2.44 % | $ 1.47 B |  Jersey |
 |
Molina Healthcare
MOH
|
109 M | $ 208.4 | -3.79 % | $ 11 B | USA |
 |
Anthem
ANTM
|
1.03 B | - | -2.32 % | $ 107 B | USA |
 |
Centene Corporation
CNC
|
895 M | $ 69.75 | -5.95 % | $ 34.4 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
4 B | $ 393.59 | -0.48 % | $ 357 B | USA |
 |
CVS Health Corporation
CVS
|
112 M | $ 83.71 | 2.93 % | $ 106 B | USA |